OSE Immunotherapeutics Dividend
Dividend criteria checks 0/6
OSE Immunotherapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 1.8% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -€1.07 |
Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
We Think OSE Immunotherapeutics (EPA:OSE) Has A Fair Chunk Of Debt
Oct 02We Think OSE Immunotherapeutics (EPA:OSE) Has A Fair Chunk Of Debt
Apr 30OSE Immunotherapeutics SA (EPA:OSE) Analysts Are Way More Bearish Than They Used To Be
May 11Is OSE Immunotherapeutics (EPA:OSE) A Risky Investment?
May 08Imagine Holding OSE Immunotherapeutics (EPA:OSE) Shares While The Price Zoomed 322% Higher
Mar 16How Is OSE Immunotherapeutics' (EPA:OSE) CEO Paid Relative To Peers?
Dec 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if OSE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if OSE's dividend payments have been increasing.
Dividend Yield vs Market
OSE Immunotherapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (OSE) | n/a |
Market Bottom 25% (FR) | 1.9% |
Market Top 25% (FR) | 5.2% |
Industry Average (Biotechs) | 1.8% |
Analyst forecast in 3 Years (OSE) | 0% |
Notable Dividend: Unable to evaluate OSE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate OSE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate OSE's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as OSE has not reported any payouts.